Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
135
Total Claims
$793K
Drug Cost
16
Beneficiaries
$50K
Cost/Patient
Risk Score Breakdown 36/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,372 Medical Oncology providers
+216%
Opioid rate vs peers
18.5% vs 5.9% avg
+306%
Cost per patient vs peers
$50K vs $12K avg
+644%
Brand preference vs peers
100.0% vs 13.4% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid rate is 216% above Medical Oncology peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
18.5%
Opioid Rate
25
Opioid Claims
$351
Opioid Cost
48.0%
Long-Acting Rate
Brand vs Generic
Brand: 91 claims · $792K
Generic: 0 claims · $0
Patient Profile
72
Avg Age
—
Female
1.80
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About